WILLARD O. THOMPSON, M.D., F.A.C.P.; SAMUEL G. TAYLOR III, M.D.; KARL A. MEYER, M.D.
During the past 50 years much has been written about the surgical management of patients with toxic goiter. Just before the introduction of iodine 12 years ago, the operative mortality had shown a steady reduction with increasing experience until, in the best clinics, it varied from 1 to 4 per cent. Not only had the mortality as a whole shown a marked reduction, but the mortality record of every thyroid surgeon had shown a marked decrease as his experience increased. This drop in the mortality rate may be attributed to two factors: (1) increase in surgical skill and improvement in
Learn more about subscription options.
Register Now for a free account.
THOMPSON WO, TAYLOR SG, MEYER KA. FACTORS INFLUENCING OPERATIVE MORTALITY IN EXOPHTHALMIC GOITER(FACTORS INFLUENCING OPERATIVE MORTALITY IN EXOPHTHALMIC GOITER*). Ann Intern Med. 1934;8:350–359. doi: 10.7326/0003-4819-8-3-350
Download citation file:
Published: Ann Intern Med. 1934;8(3):350-359.
Endocrine and Metabolism, Thyroid Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only